about
Treatment of hepatic encephalopathy: it's not lactuloseEndotoxemia produces coma and brain swelling in bile duct ligated rats.The molecular pathogenesis of hepatic encephalopathy.Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.Dispelling myths in the treatment of hepatic encephalopathy.Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis.How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.Subacute liver failure secondary to black cohosh leading to liver transplantation.Pathophysiology of cerebral oedema in acute liver failure.Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*.Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.Systemic inflammation and ammonia in hepatic encephalopathy.Inflammation and hepatic encephalopathy.Recent insights into the pathogenesis of hepatic encephalopathy and treatments.The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality.Circulating neutrophil dysfunction in acute liver failure.Clinical science workshop: targeting the gut-liver-brain axis.Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure.The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.Dysfunctional neutrophil effector organelle mobilization and microbicidal protein release in alcohol-related cirrhosis.Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure.Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase.High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System.Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.The 6-month abstinence rule in liver transplantation.Delayed opioid withdrawal-like reaction in primary biliary cirrhosis following naloxone therapy.Neutrophil CD64 expression is elevated in acetaminophen-induced acute liver failure.Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy.Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.Ammonia impairs neutrophil phagocytic function in liver disease.Salivary microbiota-immune profiling in cirrhosis: could this be the noninvasive strategy that will revolutionize prognostication in hepatology?Lamotrigine and the risk of fulminant hepatic failure.The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS).Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal?Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
P50
Q24563355-F7BF1542-8696-4BD8-BBA6-E0034DD545D1Q31113639-E9AA0258-863A-4A31-A015-AF8D8BDFF9D2Q35131691-FD86543A-B204-4C1D-8841-15E512ADAF14Q35642846-20AB3746-53D4-48E5-A2E7-CB1D20CB0122Q36023973-59DCE122-63A5-42CD-B067-ADBAF5BDF7E3Q36259154-602479F1-2803-43C4-B110-A4F64847F322Q36924678-0F9B98E2-82D5-4C11-B018-FFFB597C9A3CQ36947936-B7F53BED-AB4B-4791-B032-D263D0D8F0B8Q37076989-3F5E5A2D-3902-4E37-A03B-B5656F74C32BQ37439894-00356BC1-0047-4276-99A4-E52748C30700Q37612383-95B10869-7241-4A1E-A98F-5ACE650DB7B8Q37838478-E0EA07BD-2A3C-4B6C-A05C-36A5FE8BC74BQ38065978-2566EA5F-C8D1-4AD1-A9A2-D82BAE039978Q38098763-4CBB13E1-3195-420F-9C54-66B4994DD9B9Q38162913-FDEA7D7F-F3D5-404E-9F90-AA6F078EC0F6Q38305503-B4049FCA-D7CF-4765-8102-B8EBA7265C01Q38320684-468D4D40-76F2-426D-ADC6-05AD13E3F97CQ38601692-51FBD299-6C68-4C10-86C3-4CFCA4BAB475Q38607116-C87CB19B-ACB1-4515-A999-526B8E4C8214Q39942156-A969C8BF-02E0-459E-8416-DEA5FE031E27Q40161364-02EFE7E9-2D75-4E5A-B1A0-BBFC615D1DDAQ40441861-F4A0B887-76B8-4BED-A10B-AE056F9136D5Q40798354-1D454A85-7CC2-4870-8567-7C50E7FAE4DDQ41435123-F90E646F-FAD1-47D0-9D49-C70E5D8B3DD0Q41615059-0319336C-3443-4FAA-BE33-0353F9E26995Q42186651-66C7B57C-B792-45D8-983B-E3782F34607AQ42732353-EE1FD71B-3857-4256-B717-1EF5829A445AQ42843892-0CD61CE4-858E-4889-90FB-9DE2C4B29067Q42959393-88786900-A9EC-4CD3-8E74-77A8D7E55167Q43731043-AC8FBF51-E65C-460E-B1EA-182D4C80E461Q44069028-50CD3995-1876-410D-B911-875E1FC7154AQ44759297-5F94B9F8-DA43-4067-8F01-835273A586BDQ44886424-F14928C4-F166-4937-9566-53EBC1174121Q46433867-48FD6F15-307D-481D-9FA2-2140183CB54BQ46725701-F33C3D81-F0BF-4E7B-BE71-3BD3CE426831Q46737606-F73ED144-FF84-43DD-A6D0-C51D3C85DA90Q47724879-4C3BE1B5-659A-43D5-9E17-4B5C3BDB1A74Q47762432-6EF86D43-29A9-4DCF-8F58-CDA673BDDC4BQ48007469-0402AF38-754B-4CDA-8A86-DFC0BA250AD9Q48105576-34839F0B-B642-4C7F-9AF0-1D0E5F675D4F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Debbie L Shawcross
@ast
Debbie L Shawcross
@en
Debbie L Shawcross
@es
Debbie L Shawcross
@nl
type
label
Debbie L Shawcross
@ast
Debbie L Shawcross
@en
Debbie L Shawcross
@es
Debbie L Shawcross
@nl
prefLabel
Debbie L Shawcross
@ast
Debbie L Shawcross
@en
Debbie L Shawcross
@es
Debbie L Shawcross
@nl
P106
P31
P496
0000-0001-6133-4619